Wells Fargo Maintains Overweight on Johnson & Johnson, Raises Price Target to $287

Wells Fargo analyst Larry Biegelsen has maintained an Overweight rating on Johnson & Johnson (NYSE: JNJ) and raised the price target from $275 to $287. This adjustment reflects a positive outlook for the company's stock performance.